BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Dihematoporphyrin Ether

The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (HEMATOPORPHYRIN PHOTORADIATION); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of PHOTODYNAMIC THERAPY in the United States.

102+ PubMed studies analyzed · Evidence Score: 37.7

Research Domains

Dihematoporphyrin Ether has been studied across 12 research domains including 🔬 Oncology, ✨ Skin & Hair, 😴 Sleep, 🫁 Respiratory, 🧠 Focus & Attention. The primary research focus is 🔬 Oncology with 62% of studies addressing this area.

Loading evidence profile...

This evidence profile for Dihematoporphyrin Ether is generated deterministically from 102 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.